Fish oil

Quick links to important sections

Fish oil

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fish oil

Quick Facts

Property Description
Active ingredient Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA), Retinol (Vitamin A), Cholecalciferol (Vitamin D)
Form Oral liquid (Oil) or Softgel capsules
Pharmacological class Essential fatty acid source, Vitamin supplement
Common purpose Nutritional support, maintenance of cardiovascular health
Origin Natural source, Marine origin (Cod Liver)

What Type of Supplement is Fish Oil (Cod Liver Oil)?

Fish oil, specifically the preparation derived from Cod Liver Oil, is primarily classified as a nutritional supplement and a lipid compound of marine origin that is generally available as an oral liquid or in softgel capsules. Its components relate to the pharmacological class of an Essential fatty acid source, a classification confirming its role in providing vital nutrients.

Cod Liver Oil is a distinct natural source preparation defined as a combination product because it uniquely contains two essential fat-soluble vitamins—Retinol (Vitamin A) and Cholecalciferol (Vitamin D)—in addition to the key polyunsaturated Omega-3 fatty acids. This traditional composition distinguishes it from general Omega-3 supplements, which may contain only the fatty acids.


Composition: What Are the Active Ingredients in Fish Oil?

The main active ingredient(s) in Fish oil are the polyunsaturated Omega-3 fatty acids: Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA). The Cod Liver Oil base also naturally contains the fat-soluble vitamins, Retinol and Cholecalciferol.

These components are crucial for nutritional support. The incorporation of marine Omega-3 fatty acids supports the regulation of serum triglyceride levels, a benefit recognized for its role in maintaining cardiovascular function. The product functions as a vital supply against potential nutritional deficiency, delivering these molecules in their natural triglyceride form.


General Purpose and Foundational Health Benefits

The overall general purpose of Fish oil is to provide comprehensive nutritional support by supplying the body with crucial essential fatty acids and vitamins for systemic function. A typical neutral use scenario involves individuals seeking daily dietary reinforcement, especially when marine food sources are scarce.

The supplement is generally used to promote cardiovascular health and overall systemic wellness. EPA and DHA influence natural anti-inflammatory processes within the body. The core benefit is that the supplement helps sustain the body's balance by providing essential nutrients that modulate inflammatory signaling and support optimal cellular operation.

Regulatory References

  1. Omega-3 fats - Good for your heart
  2. Fish oil – how does it reduce plasma triglycerides?
  3. Marine omega-3 fatty acids and inflammatory processes

What side effects are possible with Fish oil?

Possible Side Effects and Safety Information

The following safety information is strictly based on adverse reactions and official statements documented by authoritative government regulatory bodies (e.g., FDA, EMA).

Adverse Reactions by Frequency

Adverse reactions associated with fish oil (Omega-3-acid ethyl esters) are categorized by frequency, with most common effects related to the gastrointestinal system.

Frequency Classification Examples of Adverse Reactions (SOC)
Very Common / Common Nausea, Flatulence, Dyspepsia (Indigestion)
Uncommon Diarrhea, Vomiting, Gastroesophageal reflux disease, Hypersensitivity, Gastrointestinal haemorrhage
Rare Urticaria, Haemorrhagic diathesis (bleeding tendency), Increased liver enzymes (Transaminases)
Frequency Not Known Angioedema (swelling beneath the skin)

Serious Adverse Reactions and Key Safety Warnings

Regulatory documents identify specific risks that establish the medication's safety limits:

  • Risk of Bleeding: Caution is officially advised due to the potential for increased bleeding time. This is a crucial safety consideration, especially for individuals using concurrent medications that affect blood clotting (e.g., anticoagulants or antiplatelet agents).
  • Hypersensitivity: The medicine is contraindicated (should not be used) in patients with known hypersensitivity or allergy to the active substance or any of its ingredients. Serious allergic reactions, such as angioedema, have been reported.
  • Liver Enzyme Monitoring: In certain patients, particularly those with pre-existing liver issues, official labeling may recommend the monitoring of liver enzymes (e.g., transaminases) to assess safety during use.

This structured information represents the official regulatory view of the product's safety profile, focusing solely on documented risks and limitations.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Fish oil (Cod Liver Oil) is structured around the accumulation and toxicity of its fat-soluble components, Retinol (Vitamin A) and Cholecalciferol (Vitamin D). Regulatory documents describe manifestations of Hypervitaminosis, including persistent headache, vomiting, dizziness, and skin peeling, alongside systemic changes like polyuria (frequent urination) and anorexia. Physiological findings often include laboratory confirmation of elevated serum vitamin levels and hypercalcemia (elevated serum calcium levels).

Overdose may progress to severe, life-threatening outcomes documented in regulatory labels, such as renal failure, cardiac arrhythmias, increased intracranial pressure, and an elevated risk of dangerous internal bleeding. Due to the potential for these complications, official guidance mandates that individuals seek prompt medical attention and contact a poison control center or emergency room at once if overdosage is suspected.

No specific antidote is known for this overdose. Management involves symptomatic and supportive care, including discontinuing the supplement and using measures like IV hydration to manage hypercalcemia. Population-specific considerations documented in labeling note that children and infants are more susceptible to Vitamin A toxicity at lower doses, and there is a risk of fetal harm (teratogenic effects) if excessive Vitamin A is taken during pregnancy.

Therapeutic Uses of Fish oil

Fish oil is commonly used as a dietary supplement that may support various aspects of cardiovascular health. It is an option considered for individuals seeking to help manage elevated levels of triglycerides (a type of blood fat). The active components, Omega-3 fatty acids, are associated with the maintenance of healthy blood pressure already within the normal range.

The supplement may also be used to support patient well-being related to joint comfort. It may help alleviate discomfort and stiffness associated with certain joint conditions, providing a supportive measure alongside primary treatments. Fish oil is widely incorporated into regimens to address nutritional needs and support overall health.


Quick Fact: Therapeutic Domains

Fish oil may support management of elevated blood lipids, contribute to joint comfort, and maintain cardiovascular health.

Eligibility and Restrictions for Use

Who Can and Cannot Use Fish Oil (Omega-3 Acid Ethyl Esters)

Official regulatory guidelines define population eligibility for prescription-grade omega-3 preparations based on specific medical conditions and age constraints.


Eligibility Status

Classification Status According to Regulatory Documents
Allowed Population Adults with severe hypertriglyceridemia (triglyceride levels ge500 mg/dL), as an adjunct to diet.
Contraindicated Patients with known hypersensitivity to the omega-3 acid ethyl esters or any component of the formulation.

Age and Condition Restrictions

Pediatric patients are a use-not-established group, as safety and effectiveness have not been defined in this population. Use in pregnant women is restricted to cases where the potential benefit justifies the potential risk to the fetus, and the components can pass into breast milk.

Restrictions apply to certain conditions: patients with hepatic impairment require periodic liver enzyme monitoring. Individuals with underlying lipid-contributing issues, such as diabetes mellitus or hypothyroidism, should have those conditions controlled before therapy is considered. Additionally, patients with paroxysmal or persistent atrial fibrillation or flutter are flagged for caution due to recurrence risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for fish oil, particularly preparations derived from Cod Liver Oil, defines interactions across three primary domains: coagulation effects, absorption modification, and supplement overlap. These interactions are documented based on pharmacodynamic and pharmacokinetic principles, and they result in specific monitoring requirements and administration constraints.

Documented Pharmacodynamic Interactions

Co-administration with anticoagulant and antiplatelet agents is documented to result in the prolongation of bleeding time. Patients receiving these combinations should be monitored periodically. Additive pharmacodynamic effects may also occur with antihypertensive and antidiabetes drugs, leading to a documented risk of excessive blood pressure or blood sugar lowering.

Exposure and Timing Constraints

Interactions that alter systemic exposure include the potential for fish oil to increase the plasma concentration of certain immunosuppressants (e.g., Cyclosporine). The lipase inhibitor Orlistat is documented to reduce the absorption of Omega-3 fatty acids and fat-soluble vitamins, necessitating administration be separated by at least two hours. Furthermore, oral contraceptive drugs are documented to reduce the triglyceride-lowering efficacy of the product.

Supplement Overlap

As Cod Liver Oil contains Vitamin A and Vitamin D, co-administration with other supplements containing these specific fat-soluble vitamins is restricted due to the documented risk of Hypervitaminosis.

Mechanism of Action

Fish oil is a source of omega-3 polyunsaturated fatty acids (PUFAs), primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which incorporate into cellular membrane phospholipids, particularly in immune, cardiac, and neural tissues. This incorporation modifies membrane fluidity and alters the function of embedded membrane proteins, including ion channels (e.g., Na^+ and Ca^2+ channels), modulating cellular excitability.

EPA directly competes with arachidonic acid (AA) for the enzymes cyclooxygenase (COX) and lipoxygenase (LOX). This competitive inhibition results in the production of less pro-aggregatory and less pro-inflammatory eicosanoids (3-series prostaglandins, 5-series leukotrienes) in place of AA-derived products (2-series prostaglandins, 4-series leukotrienes). Furthermore, EPA and DHA are metabolized into specialized pro-resolving mediators (SPMs), such as resolvins and protectins, through COX and LOX pathways. SPMs act as agonists at specific G protein-coupled receptors ( GPCRs), downregulating pro-inflammatory signaling cascades, inhibiting leukocyte migration, and promoting the termination of the inflammatory response.

Intracellularly, omega-3 PUFAs act as agonists for Peroxisome Proliferator-Activated Receptors ( PPARs), especially PPARalpha and PPARgamma. PPAR activation leads to changes in gene expression, increasing the transcription of enzymes involved in mitochondrial and peroxisomal beta-oxidation of fatty acids, and decreasing the expression of transcription factors like Sterol Regulatory Element-Binding Protein 1c ( SREBP-1c), which regulates lipogenesis. This modulates hepatic lipid metabolism and systemic circulatory lipid profiles.

Dosage and Administration Information

The high-dose prescription form of Omega-3-acid ethyl esters is administered exclusively by the oral route using softgel capsules. The dosing regimen established for treating severe hypertriglyceridemia requires a total intake of 4 grams per day. This standard daily dose may be administered either as a single 4-gram dose once daily or divided into two separate 2-gram doses to be taken twice daily.

Instructions for use require the softgel capsules to be swallowed whole and should not be crushed, dissolved, or chewed to maintain proper administration integrity. The medicine is generally directed to be taken with meals. The entire course of therapy is defined as an adjunct to an appropriate lipid-lowering diet that must be established and continued throughout the usage period.

Regarding use in specific populations, safety and effectiveness have not been established in pediatric patients. Furthermore, procedural management of the medicine requires periodic monitoring of laboratory parameters, including LDL-C levels and liver enzymes (ALT and AST), during the treatment course. These instructions collectively define the standardized approach for using the high-dose product.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fish Oil

Evidence for Managing Very High Triglyceride Levels

Research for this use involves high-quality Randomized Controlled Trials (RCTs) and Systematic Reviews that focused on adults presenting with significantly elevated fasting blood triglyceride levels, typically those measuring 500 mg/dL or higher. These studies monitored key outcomes related to systemic imbalance, specifically measuring changes in the serum triglyceride biomarker over short-to-intermediate treatment periods. Findings from numerous trials consistently reported patterns observed in the studies regarding the triglyceride biomarker in the observed patient populations. The research also described variations in other lipid biomarker readings; an association with a small, concurrent increase in LDL cholesterol was observed in some studies.


Evidence for Cardiovascular Outcomes in High-Risk Patients

Research involves numerous large-scale, longer follow-up duration RCTs that followed patients for several years. These studies focused on adults with established heart disease, particularly those who had experienced a prior myocardial infarction. The primary research outcomes were large, time-to-event measures, such as cardiovascular death, all-cause mortality, and the occurrence of major adverse cardiovascular events (MACE). Early, long-running trials exploring this research question reported some specific patterns of event rates in specific high-risk patient groups. However, subsequent clinical trials and large-scale meta-analyses have described inconsistent findings, with data showing patterns related to the specific formulation (pure EPA versus EPA/DHA combinations) and the dose levels used.


What Remains Uncertain About the Research

Research highlights that the evidence landscape contains key limitations. For instance, in cardiovascular outcomes, the high degree of heterogeneity (variability) and inconsistent findings across large-scale trials means the overall certainty remains low for broad population-level prevention. For conditions like inflammatory joint discomfort, the evidence quality varies for non-inflammatory conditions, and data for long-term functional improvement are limited. Overall, research provides context but not individual predictions, and data for certain subgroups and comparative long-term outcomes remain insufficient to draw definitive conclusions.

Key Studies & References

  1. Omega-3 Fatty Acids (EPA and DHA): Health Professional Fact Sheet, NIH Office of Dietary Supplements

Frequently Asked Questions (FAQ)

Common questions about Fish oil (FAQ)


Q: What is the difference between prescription fish oil and the supplements I buy at the store?

Prescription fish oil products are specifically approved by regulators to treat medical conditions, such as severe hypertriglyceridemia, at a defined, high dose. These products are subject to strict regulatory oversight regarding their purity, safety, and effectiveness. In contrast, over-the-counter supplements are not regulated as drugs, and their composition, testing, and intended purpose may differ significantly.

Q: Do you need a prescription to get fish oil or is it always over-the-counter?

Fish oil products are available in both forms, depending on the specific formulation and dose. High-concentration products used to treat medical conditions, such as severe hypertriglyceridemia, are typically classified as prescription-only drugs. Other fish oil products are widely available as over-the-counter (OTC) nutritional supplements.

Q: What is the general safety classification for fish oil by health organizations?

Fish oil is generally classified as a lipid compound and an essential fatty acid source. It functions primarily as a nutritional supplement to provide the body with vital Omega-3 components. The high-dose versions are classified by regulatory bodies as prescription medicines for specific indications.

Q: Are there different forms of fish oil, like ethyl esters or triglycerides?

Yes, fish oil is available in different chemical forms. The natural form found in fish is typically the triglyceride (TG) form. Prescription-grade, high-concentration products often utilize the ethyl ester (EE) form, which is a processed type used to deliver precise, high doses of the active ingredients.

Q: Does fish oil actually have an expiration date?

Yes, official drug and supplement products have a defined shelf life and an expiration date printed on the label. The product must be stored correctly, protected from heat, light, and moisture, to ensure the stability of the Omega-3 fatty acids up until that date.

Q: Why are some fish oil products labeled 'enteric-coated'?

Enteric coating is a layer applied to a capsule that prevents it from dissolving in the stomach. The coating is generally used to prevent dissolution in the stomach, which may be intended to address digestive side effects such as a fishy aftertaste or burping.

Q: How long does it usually take to see any effect from fish oil?

Regulatory documents indicate that the prescribed use of fish oil involves regular assessment and periodic monitoring of laboratory parameters, such as triglyceride levels. This suggests that the product's effects are measured and assessed over the entire treatment course rather than immediately after administration.

Q: Is fish oil described as being beneficial for heart health in general?

The official indication for the high-dose product is the treatment of severe hypertriglyceridemia, which is a risk factor for heart issues. Research documents also explore the product's effect on major cardiovascular outcomes in high-risk patients. However, clinical studies focusing on prevention in the general population have been described as inconsistent across large-scale trials.

Q: Is it true that fish oil can sometimes cause fishy burps?

Official product information lists common gastrointestinal adverse effects, including flatulence and dyspepsia (indigestion). The tendency for a fishy aftertaste or burping is related to these digestive effects. Official administration instructions generally direct the product to be taken with meals.

Q: Do pregnant or breastfeeding people need special considerations before using fish oil?

Yes, specific considerations are required. Regulatory documents restrict the use of fish oil in pregnant women to cases where the potential benefit is judged to outweigh the potential risk to the fetus. Additionally, the components of fish oil can pass into breast milk, and these factors are subject to specific consideration as part of the product’s use conditions.

Q: Is it okay to take fish oil if I'm already taking a daily vitamin?

Cod Liver Oil products contain the fat-soluble vitamins A and D. Official warnings state that co-administration with other supplements containing these specific fat-soluble vitamins is restricted. This is due to the documented risk of Hypervitaminosis (excessive vitamin levels).

Q: Can fish oil be used alongside common pain relievers?

Some common pain relievers, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can have antiplatelet effects, meaning they affect blood clotting. Official warnings state that the use of fish oil with antiplatelet agents may prolong bleeding time. Regulatory documents describe that use with antiplatelet agents requires caution.

Q: Can fish oil interact with blood thinning medications?

Yes, regulatory documents describe a pharmacodynamic interaction. Co-administration of fish oil with anticoagulant or antiplatelet agents may result in the prolongation of bleeding time. Regulatory documents state that periodic monitoring of patient parameters is required when this combination is used.

Q: Why might a person be advised to stop taking fish oil before surgery?

Official warnings note the potential for increased bleeding time. The decision to temporarily stop the product prior to a procedure is a clinical decision based on this safety profile.

Q: Does taking fish oil change my cholesterol levels?

Clinical trial data indicate that the product is effective at reducing very high triglyceride levels. However, in some studies, an association with a small, concurrent increase in LDL cholesterol (often referred to as 'bad' cholesterol) has been observed.

Q: Do people with shellfish or finned fish allergies need to avoid fish oil entirely?

The product is strictly contraindicated for anyone with a known hypersensitivity or allergy to the active substance or any ingredient in the formulation. Official health sources state that it is not clearly established whether individuals with finned fish or shellfish allergies can safely use all fish oil products.

Q: Does fish oil affect liver enzymes or kidney function tests?

Official instructions require the periodic monitoring of liver enzymes, specifically ALT and AST, during the treatment course. An increase in these liver enzymes is also listed as a rare adverse reaction in regulatory documents. There are no comparable official statements regarding routine monitoring of kidney function tests.

Q: What are the differences between fish oil, krill oil, and flaxseed oil?

Fish oil provides the Omega-3 fatty acids EPA and DHA. Krill oil also provides these Omega-3s, typically in the form of phospholipids. Flaxseed oil provides a different plant-based Omega-3 called alpha-linolenic acid (ALA), which the body must convert into EPA and DHA.

Q: Can taking fish oil affect the results of certain medical tests?

Yes, the product requires the periodic monitoring of laboratory tests. These include LDL cholesterol and liver enzymes (ALT and AST), as these specific test results are known to be affected by the use of the product.

Q: What does a high-level review of the clinical trials on fish oil generally conclude?

The overall research evidence provides context but not individual predictions regarding outcomes. Official documents highlight key limitations, stating that data for certain patient subgroups and long-term comparative outcomes remain insufficient to draw definitive conclusions for all indications.

Q: Is the research evidence for fish oil consistent across different studies?

Official documents reviewing clinical trials describe the research landscape as containing a high degree of heterogeneity, meaning there is significant variability among studies. This has led to inconsistent findings across large-scale trials, particularly concerning major cardiovascular outcomes in broad populations.

Q: Is it safe to use fish oil for a long period of time?

Research supporting the initial use included large-scale clinical trials with long follow-up durations extending for several years. However, regulatory documents also highlight that the data regarding long-term functional improvement and safety for all indications and patient groups are considered insufficient to draw definitive conclusions.

Q: Do regulatory bodies list specific warnings for individuals with an implanted cardiac device?

Recent safety updates have noted an increased risk of developing atrial fibrillation or flutter in patients with established cardiovascular disease or risk factors. Official documents describe that the use of the product requires caution in individuals with pre-existing or risk factors for atrial fibrillation or flutter.

Q: What are the possible risks described in official warnings for fish oil?

Official warnings focus on several key safety considerations. These include the risk of increased bleeding time, particularly when used alongside other blood-thinning medicines. Caution is also advised regarding the periodic monitoring of liver enzymes in certain patient populations.

How should Fish oil be stored and disposed of?

Fish oil products must be stored under specific conditions defined in official regulatory labeling to ensure the stability of the Omega-3 fatty acids.

Official Storage Requirements

Item Requirement
Temperature Store at controlled room temperature (20 C to 25 C), with permissible excursions up to 30 C.
Protection Protect from light and moisture; keep away from excess heat and do not freeze.
Container Store in the original container and keep the cap tightly closed.
Child Safety Keep the product out of the sight and reach of children.

Disposal Requirements

Unused or expired fish oil must be disposed of according to official guidelines. Do not flush the medicine down the toilet. Follow the general FDA guidelines, which recommend mixing the product with an undesirable substance (such as used coffee grounds) in a sealed bag and discarding it in the household trash. Disposal must be completed in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fish oil found in:

A-Z Index: